Telegram RegisterThe public register of Telegram

Channel

miRas Biotech

@miRasBiotech

On this record: Growth · Engagement · What this channel posts · Reactions · Posts · Citations · Cite this entry

521subscribers

+0 since we began measuring on 6 August 2026

Risers and fallers across the register · movement among entries of Under 1,000.

Register entry

Telegram ID-1001648285069
TypeChannel
Username@miRasBiotech
DescriptionOffering all types of oligonucleotides (miRNAs, siRNAs, ASOs, antagomiRs, etc) for basic and animal research Admin: @miRasAdmin; @miRasPR Phone: 02122338248 🌍 www.miras-biotech.com 💌Email: mirasbiotech@gmail.com 🚩Insta: www.instagram.com/mirasbiotech
CreatedBetween 1 December 2021 and 31 March 2023— estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded6 August 2026
Last confirmed live7 August 2026
Measurements held2
On Telegramt.me/miRasBiotech

Growth

5216 Aug 2026, 09:23 — 521 subscribers6 Aug 2026, 18:32 — 521 subscribers6 Aug 2026, 09:236 Aug 2026, 18:32
2 measurements taken within a single day. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 520–522 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
6 Aug 2026, 18:32521no change
6 Aug 2026, 09:23521first reading

Engagement

19 posts held, back to 22 September 2025the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 pageof Telegram’s post history, 20 posts per page.

ERR · 30 days
6.91%
avg views ÷ 521 subscribers
Avg views / post
36.0
1 post measured
Reaction rate
13.9%
reactions ÷ views · ER floor
Posts in window
1
of 19 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views— note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate.

What these figures were computed from
WindowRolling 30 days · latest post in window 4 August 2026
Posts held19 (22 September 20254 August 2026)
Views total36
Reactions total5
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken6 Aug 2026, 18:32 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

What this channel posts

Photos
350
Videos
20
Links
83

Lifetime counters from Telegram’s own channel header, read 6 August 2026 — not the date at the top of this page, which is when the subscriber count was last read. Below Telegram’s rounding threshold, so these counts are exact.

Reaction mix

71 reactions across 15 posts, in 5 distinct kinds. The most used accounts for 64.8% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
4664.8%
👍1521.1%
👌811.3%
👎11.41%
🔥11.41%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 15 of the 19 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 71reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 19 most recent posts we hold, published 22 September 2025 to 4 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

4 Aug 2026, 19:56 UTC36 views5 reactionsread 6 August 2026
Photo

✴️ مولکول‌های #siRNA برای هدف‌گیری دقیق ژن های دخیل در فرآیندهای فیزیولوژیک و تکوینی و نیز سرکوب ژن‌های موثر در ایجاد و پیشرفت بیماری‌ها، مورد استفاده قرار می گیرند. ✅ شرکت زیست‌فناوری #میراث با بهره‌گیری از طراحی دقیق و اصلاحات شیمیایی ویژه، انواع مولکول‌های siRNA را علیه همه ژن‌های انسانی و‌ حیوانی طراحی و تولید می‌کند. این siRNAها به گونه‌ای توسط متخصصان میراث طراحی می‌شوند که فقط ژن هدف را سرکوب کنند و بخاطر داش

5

12 Jul 2026, 09:31 UTC109 viewsread 6 August 2026

از من بپرسید: #microRNA #siRNA #ASO #antisense #oligo #probe #oligonucleotide, #primer @miRasAdmin 😊

11 Jul 2026, 18:25 UTC73 views5 reactionsread 6 August 2026
Photo

🔔🔔توجه توجه مشتریان گرامی اساتید ارجمند پژوهشگران گرانقدر 🔴 به اطلاع می‌رسانیم، میراث همه انواع الیگونوکلئوتیدهای موردنیاز برای پیشبرد پروژه های شما عزیزان را در سری تولید جدید ثبت سفارش می‌کند. محصولات موجود ظرف مدت 3 الی 5 روز کاری و محصولات سفارشی در طول مدت یک الی دو ماه تقدیم حضور می‌گردد. اطلاعات بیشتر در عکس نوشته 👆🏻 همین امروز با ما در ارتباط باشید تا از این فرصت بی‌نظیر بهره‌مند شوید.☺️ ✅ راه‌های ارتب

👍5

7 Jul 2026, 08:17 UTC318 views6 reactionsread 6 August 2026

در سال‌های اخیر، چندین داروی الیگونوکلئوتیدی توسط سازمان FDA تایید شده‌اند. از این داروها، چند داروی مبتنی بر siRNA شامل: - داروی patisiran - داروی givosiran - داروی lumasiran - داروی inclisiran و - داروی vutrisiran توسط FDA آمریکا تأیید شده و به فهرست رو به رشد داروهای الیگونوکلئوتیدی اضافه شده‌اند. ✍ شرکت زیست‌فناوری #میراث به عنوان نخستین شرکت طراحی و تولیدکننده الیگونوکلئوتیدها در ایران، افتخار دارد که تاکنون ب

👍5🔥1

29 Jun 2026, 09:42 UTC150 viewsread 6 August 2026

🗒 #مصاحبه روابط عمومی شرکت زیست‌فناوری میراث با جناب آقای دکتر محمد احمدوند، دانشیار دانشگاه علوم‌پزشکی تهران 🔺لطفا خودتون رو معرفی کنید و بفرمایید در چه زمینه‌ای کار می‌کنید؟ احمدوند هستم عضو هیئت علمی دانشگاه علوم پزشکی تهران. فعالیت‌های پژوهشی ما عمدتاً در زمینه‌های مرتبط با سلول‌های بنیادی، سلول درمانی و مهار ژن‌ها با بهره‌گیری از siRNA متمرکز شده است. 🔺چه محصولاتی را از شرکت زیست‌فناوری میراث تهیه کردید؟ ما م

29 Jun 2026, 09:41 UTC119 viewsread 6 August 2026
Photo

"ما مجموعه‌ای از اولیگو‌ها شامل سه مولکول siRNA و یک الیگوی فلوروفوردار را از مجموعه میراث خریداری کردیم که کارآیی بسیار خوبی داشتند. مهار ژن‌ها توسط siRNA، به میزان ۶۰-۶۵ درصد انجام شد و با الیگوی فلوروفوردار هم توانستيم با بازده حدود ۷۲ درصد، الیگوها را به داخل سلول انتقال دهیم. تمامی مراحل بدون مشکل انجام شد و ما از عملکرد محصولات رضایت کامل داشتیم." دکتر محمد احمدوند، دانشیار دانشگاه علوم پزشکی تهران مصاحبه کوت

29 Jun 2026, 08:16 UTC111 views4 reactionsread 6 August 2026

پژوهشگران عزیز و اساتيد بزرگوار، مولکول‌های siRNA و miRNA خود را از شرکت زیست‌فناوری میراث تهیه بفرمایید. تمامی الیگونوکلئوتیدهایی از جمله آنتاگومیر و پروب و غیره که از میراث تهيه شده‌اند، همگی موفقیت‌آمیز بوده و به نتیجه مطلوب رسیده‌اند و این بزرگترین افتخار ماست. یکی از مصاحبه‌ها را در پست بعد ملاحظه بفرمایید. خیلی ممنون 🌸🌸 @miRasBiotech

3👍1

27 Jun 2026, 09:16 UTC126 viewsread 6 August 2026

هر سوالی داريد، از من بپرسید: @miRasAdmin 😊

21 Jun 2026, 13:36 UTC≈2,930 views5 reactionsread 6 August 2026
Photo

🔔🔔توجه توجه مشتریان گرامی اساتید ارجمند پژوهشگران گرانقدر 🔴 به اطلاع می‌رسانیم، میراث همه انواع الیگونوکلئوتیدهای موردنیاز برای پیشبرد پروژه های شما عزیزان را در سری تولید جدید ثبت سفارش می‌کند. محصولات موجود ظرف مدت 3 الی 5 روز کاری و محصولات سفارشی در طول مدت یک الی دو ماه تقدیم حضور می‌گردد. اطلاعات بیشتر در عکس نوشته 👆🏻 همین امروز با ما در ارتباط باشید تا از این فرصت بی‌نظیر بهره‌مند شوید.☺️ ✅ راه‌های ارتب

👌5

9 Dec 2025, 19:19 UTC333 views3 reactionsread 6 August 2026

سلام و احترام آدرس صفحات ما در تلگرام: سلول‌های بنیادی و سرطان @pluricancer بیولوژی RNA @RNA_Biology زیست‌پزشکی مولکولی @MolBioMed مهارت مقاله‌نویسی @write_paper شرکت زیست‌فناوری میراث @miRasBiotech

3

4 Dec 2025, 13:44 UTC305 views4 reactionsread 6 August 2026
Photo

در سال‌های اخیر، چندین داروی الیگونوکلئوتیدی توسط سازمان FDA تایید شده‌اند. از این داروها، پنج دارویی مبتنی بر siRNA شامل: - داروی patisiran - داروی givosiran - داروی lumasiran - داروی inclisiran و - داروی vutrisiran توسط FDA آمریکا تأیید شده و به فهرست رو به رشد داروهای الیگونوکلئوتیدی اضافه شده‌اند. ✍ شرکت زیست‌فناوری #میراث به عنوان نخستین شرکت طراحی و تولیدکننده الیگونوکلئوتیدها در ایران، افتخار دارد که تاکنون

4

4 Dec 2025, 13:43 UTC230 views5 reactionsread 6 August 2026
Photo

🔬 آیا می‌دانید در حال حاضر، چه مولکول‌های microRNAای در شرکت زیست‌فناوری میراث موجود است؟ 👈شما می‌توانید این محصولات را ظرف مدت‌ چند روز تا یک هفته دریافت نمائید. 👈محصولات microRNA شرکت میراث، با کیفیتی بی‌نظیر و‌ تحویل سریع آماده ارائه به پژوهشگران، اساتید و دانشجویان گرامی هستند. ❇️ تحقیقات گسترده‌ای در مراکز تحقیقاتی و دانشگاه‌های ایران و جهان پیرامون مولکول‌های #microRNA و مسیرهای تنظیمی آن‌ها در حال انجام است

5

Showing the 12 most recent of 19 posts we hold for @miRasBiotech. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Citation-graph rank

Citation-graph rank — 154,144 of 1,169,250entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.

Forward network

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 4 registered channels — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 6 August 2026 — this entry's latest reading, not the date you are reading this.

“miRas Biotech” (@miRasBiotech), 521 subscribers as measured 6 August 2026. Telegram Register, tgregister.com/channel/miRasBiotech.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.